gastrin 17 vaccine
Trade name: Gastrimmune
Vaccineexperimental
Clinical trial activity
16 trials · 10 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
16
Phase 3
4
Phase 4
0
Earliest trial started Oct 1, 1993 (NCT02181465)
Timeline
Indications
Mechanism of action
- Gastrin releasing peptide receptorImmunity, active
GRPR immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- antigastrin 17
- anti-gastrin 17 immunogen
- g17dt
- g17dt
- g17-dt
- g17dt (vaccine)
- gastrimmune
- gastrin-17-diphtheria toxoid conjugate
- gastrin 17 immunogen
- gastrin 17 vaccine
- gastrin 17 vaccine
- gastrin immunogen
- glu-gly-pro-trp-leu-glu-glu-glu-glu -diphtheria toxoid
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03746769 | Phase 1/Phase 2 (Phase 2) | Feb 1, 2019 | City of Hope National Medical Center, University of California, Los Angeles |
| NCT00020787 | Phase 3 | Jul 1, 2001 | National Cancer Institute (NCI), University of California, Los Angeles |
| NCT02118077 | Phase 3 | Apr 1, 2001 | Cato Research |
| NCT02118064 | Phase 2 | Mar 1, 2001 | Cato Research |
| NCT02518529 | Phase 2 | Feb 1, 2001 | Cato Research, ChapelPharma Ltd, PPD |
| NCT00044031 | Phase 3 | Feb 1, 2001 | Cato Research, The Christie NHS Foundation Trust |
| NCT03200821 | Phase 3 | Aug 14, 2000 | Cato Research |
| NCT02223078 | Phase 2 | Jul 1, 2000 | Cato Research |
| NCT02518373 | Phase 2 | Apr 1, 2000 | Cato Research |
| NCT02450032 | Phase 2 | Feb 1, 2000 | Cato Research, University of Glasgow |
| NCT02233712 | Phase 2 | Aug 1, 1999 | Cato Research, University of Liverpool |
| NCT02098239 | Phase 2 | Aug 1, 1999 | Cato Research |
| NCT02098291 | Phase 2 | Apr 1, 1999 | Cato Research |
| NCT02521649 | Phase 2 | Sep 1, 1998 | Cato Research |
| NCT02228785 | Phase 2 | May 1, 1994 | Cato Research, University of Nottingham |
| NCT02181465 | Phase 2 | Oct 1, 1993 | Cato Research |
Showing 16 of 16 trials
Page 1 / 1
Organizations
Research & Development (10)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cato Research | For profit | 14 | 14 | 2 | 1993 |
| University of California, Los Angeles | Academic/Hospital | 2 | 1 | 2 | 2001 |
| ChapelPharma Ltd | For profit | 1 | 0 | 1 | 2001 |
| City of Hope National Medical Center | Academic/Hospital | 1 | 1 | 1 | 2019 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2001 |
| PPD | For profit | 1 | 0 | 1 | 2001 |
| The Christie NHS Foundation Trust | Academic/Hospital | 1 | 0 | 1 | 2001 |
| University of Glasgow | Academic/Hospital | 1 | 0 | 1 | 2000 |
| University of Liverpool | Academic/Hospital | 1 | 0 | 1 | 1999 |
| University of Nottingham | Academic/Hospital | 1 | 0 | 1 | 1994 |
10 organizations
Page 1 / 1